Hege Sagstuen Haugnes
Overview
Explore the profile of Hege Sagstuen Haugnes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sundset R, Haugnes H, Perez A, Engelsen O, Fosseide I, Castillejo M, et al.
Tidsskr Nor Laegeforen
. 2024 Aug;
144(9).
PMID: 39166985
Background: Treatment of castration-resistant metastatic prostate cancer with [¹⁷⁷Lu]PSMA radioligand. Case Presentation: A man in his seventies with metastatic prostate cancer received castration therapy for four years, developing castration-resistant disease....
2.
Thor A, Myklebust M, Bergdahl A, Lundgren P, Skokic V, Almas B, et al.
J Urol
. 2024 Jul;
212(5):720-730.
PMID: 39052680
Purpose: The SWENOTECA-MIR prospective multicenter study aims to assess the clinical value of miR-371a-3p as a novel marker in metastatic germ cell tumor patients undergoing retroperitoneal lymph node dissection (RPLND),...
3.
Thor A, Negaard H, Bergdahl A, Almas B, Larsen S, Lundgren P, et al.
Eur Urol Open Sci
. 2024 Jul;
65:13-19.
PMID: 38966804
Background And Objective: There is an unmet need to avoid long-term morbidity associated with standard cytotoxic treatment for low-volume metastatic seminoma. Our aim was to assess the oncological efficacy and...
4.
Loffeler S, Bertilsson H, Muller C, Aas K, Haugnes H, Aksnessaether B, et al.
BJU Int
. 2024 Mar;
133(6):680-689.
PMID: 38469686
Background: Older men (aged ≥75 years) with high risk, non-metastatic prostate cancer (PCa) are increasingly treated with curative therapy (surgery or radiotherapy). However, it is unclear if curative therapy prolongs...
5.
Gerdtsson A, Negaard H, Almas B, Bergdahl A, Cohn-Cedermark G, Glimelius I, et al.
BJU Int
. 2024 Jan;
133(6):717-724.
PMID: 38293778
Objectives: To assess whether extended surveillance with repeated computed tomography (CT) scans for patients with clinical stage IIA (CS IIA; <2 cm abdominal node involvement) and negative markers (Mk-) non-seminomatous...
6.
Upreti R, Mmbaga E, Haugnes H, Kiserud C, Del Risco Kollerud R
Acta Oncol
. 2023 Oct;
62(12):1607-1615.
PMID: 37897712
Background: The aim was to investigate the distribution of health problems in general practice (GP) among adolescent and young adult (AYA) survivors of lymphoma and to compare problem rates with...
7.
Gerdtsson A, Torisson G, Thor A, Bergdahl A, Almas B, Hakansson U, et al.
BJU Int
. 2023 May;
132(3):329-336.
PMID: 37129962
Objective: To validate Vergouwe's prediction model using the Swedish and Norwegian Testicular Cancer Group (SWENOTECA) RETROP database and to define its clinical utility. Materials And Methods: Vergouwe's prediction model for...
8.
Stikbakke E, Wilsgaard T, Haugnes H, Pedersen M, Knutsen T, Stoyten M, et al.
Cancers (Basel)
. 2022 Mar;
14(5).
PMID: 35267449
The role of miR-24-1-5p and its prognostic implications associated with prostate cancer are mainly unknown. In a population-based cohort, the Prostate Cancer Study throughout life (PROCA-life), all men had a...
9.
Gerdtsson A, Thor A, Bergdahl A, Almas B, Hakansson U, Tornblom M, et al.
Eur Urol Oncol
. 2021 Mar;
5(2):235-243.
PMID: 33750683
Background: The distribution of retroperitoneal lymph node metastases for patients with nonseminoma and a residual tumour of 10-49 mm in a population-based setting is unknown. This information is needed to...
10.
Bersvendsen H, Haugnes H, Dahl A, Fagerli U, Fluge O, Holte H, et al.
Bone Marrow Transplant
. 2020 Nov;
56(4):968-970.
PMID: 33139869
Sexual function in female lymphoma survivors after high-dose therapy with autologous stem-cell transplantation (auto-SCT) is largely unstudied. Female lymphoma survivors treated with auto-SCT in Norway 1987-2008 were eligible participants (n...